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Prevention  or alleviation  of pain  in laboratory  mice  is a fundamental  requirement  of  in vivo  research.
The  mouse  grimace  scale  (MGS)  has  the  potential  to be an  effective  and rapid  means  of assessing  pain
and  analgesic  efﬁcacy  in  laboratory  mice.  Preliminary  studies  have  demonstrated  its  potential  utility  for
assessing  pain  in mouse  models  that involve  potentially  painful  procedures.  The  next  step  in validation
is to determine  if the other  procedures  that  are  integral  to these  models,  i.e. anaesthesia  or  analgesia,
result  in  any  changes  in  MGS  score  which  would  need  to be taken  into  account  when  using  this  tool  to
assess  post-procedural  pain.  Here,  spontaneous  behaviour  and  MGS  data  for CBA  and  DBA/2  mice  were
recorded  at  baseline  and  following  either  isoﬂurane  anaesthesia  (suitable  to  perform  abdominal  surgery)
or  0.05  mg/kg  s.c. buprenorphine.  In line  with previous  studies,  isoﬂurane  anaesthesia  alone  had  limited
effects  on  the  spontaneous  behaviour  in  either  strain  of mice.  Administration  of buprenorphine  resulted
in  increased  periods  of  activity  e.g.  walking  and  chewing  bedding  in  CBA  mice.  These  effects  were  not
demonstrated  in DBA/2  mice.  In comparison,  buprenorphine  alone  had  no impact  on MGS  score  in  either
strain  of mice,  however  DBA/2  mice  showed  a signiﬁcant  increase  in  MGS  score  following  isoﬂurane
anaesthesia.  The  presence  of this  increased  MGS  score  must  be taken  into  account  when  attempting  to
use the  MGS to assess  pain  in  DBA/2  mice.  Further work  should  be carried  out  to  establish  the presence
of  this  isoﬂurane  effect  in  other  strains  and  the  potential  inﬂuence  of gender  on  the  MGS. This  further
validation  is  necessary  prior  to implementation  of this  technique  in  clinical  scenarios.
ublis©  2015  The  Authors.  P
. Introduction
Prevention or alleviation of pain in laboratory animals is a funda-
ental requirement of in vivo research. This is particularly critical
or laboratory mice, as they comprise the greatest number of ani-
als used, and this number is increasing annually with the growth
f research using genetically modiﬁed models (Home Ofﬁce, 2012).
ith this increasing diversity of mouse strains and models in com-
on  use, we need to ensure that our means of assessing pain and
nalgesic efﬁcacy are both effective and clinically applicable across
ouse strains. To date, many of the studies carried out to develop
nd validate indices of pain in mice have not looked at effect of
train. In those that have strain has been shown to have a signiﬁcant
ffect on behaviour, responses to routine anti-nociceptive testing,
nd analgesia and anaesthesia efﬁcacy (Kim et al., 2005; Mogil et al.,
999; Kest et al., 2002; Groeben et al., 2003; Dickinson et al., 2009).
In order for an index of pain to be applied clinically we need
o establish its validity by ensuring the measure relates directly
∗ Corresponding author.
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168-1591/© 2015 The Authors. Published by Elsevier B.V. This is an open access article uhed  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
to pain, that it can be easily and rapidly carried out with a min-
imum of interference to both the animals and care staff and
that it can be measured accurately with little variation between
or within observers. Recently, spontaneous ‘pain’ behaviour and
facial expressions have been investigated as a means of effectively
assessing pain in laboratory mice (e.g. Leach et al., 2012; Miller
et al., 2012; Wright-Williams et al., 2013).
Following vasectomy, key changes in behaviour have been iden-
tiﬁed in male CD1 mice (Miller et al., 2012; Leach et al., 2012).
These include decrease in the presence of normal exploratory
behaviours including rearing from pre to post-op and the presence
of abnormal, ‘pain’ behaviours including twitching and writhing,
post-op which are not presented under baseline conditions. These
changes in behaviour are reduced by administration of an anal-
gesic but not prevented (e.g. Leach et al., 2012). Manual scoring of
mouse behaviour is however extremely time consuming, limiting
the number of strains of mice, procedures and analgesics that can
be screened for effectiveness.The mouse grimace scale (MGS) devised by Langford et al. (2010)
is being considered as a potentially accurate and reliable means
of scoring pain in mice. Langford et al. (2010) demonstrated an
increase in MGS  score following a range of potentially painful
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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rocedures including laparotomy. In a further study MGS  was
hown to be potentially valid for assessing pain associated with
crotal approach vasectomy in CD1 mice (Leach et al., 2012), where
 signiﬁcant increase in MGS  score was observed from pre to
ost surgery. This effect was reduced by the administration of an
nalgesic. An identical pattern was also observed when manually
coring key, previously identiﬁed, pain associated behaviours in the
ame mice.
When validating these ‘pain associated’ behaviours and facial
xpressions for assessing pain under clinical conditions, we need
o ensure that the other non-painful procedures that are integral
o the research being carried out (e.g. anaesthesia or analgesia) are
ither minimal or that the magnitude of the effect is understood and
an be taken into account when assessing mice. Although, previous
tudies have demonstrated that procedures such as administration
f buprenorphine can causes behavioural changes in mice such as
lterations in activity levels (Cowan et al., 1977; Tubbs et al., 2011;
right-Williams et al., 2013), to date the effect of the majority of
outinely used analgesics or anaesthetics on the MGS  in animals
ot in pain has not been assessed.
Following a surgical procedure, mice are often not adminis-
ered analgesia (Richardson and Flecknell, 2005; Stokes et al., 2009).
hen analgesia is provided to laboratory mice, it is given in a range
f scenarios, which do not all involve general anaesthesia. It was
herefore decided to study the effects of isoﬂurane and buprenor-
hine separately to provide data that is relevant in a range of clinical
cenarios. Here, we aim to study two common strains of laboratory
ice, CBA and DBA/2, to determine if the administration of anaes-
hetic (isoﬂurane) or an analgesic (buprenorphine) alone results in
hanges in MGS  score or spontaneous behaviour.
. Materials and methods
All procedures were conducted in accordance with the Animals
Scientiﬁc Procedures) Act 1986, European Directive EU 2010/63
nd with the approval of Newcastle University Animal Welfare and
thics Board.
.1. Animals
Eight CBA and Eight DBA/2 male mice (Charles River Laborato-
ies Inc, Kent) weighing 25.6–28.7 g (CBA) and 23.3–26.3 g (DBA/2)
t the start of the study were used. Mice were housed in same
train groups of 4 in individually ventilated cages (IVCs) (Type 2 –
rrowmight, Hereford, UK) with sawdust bedding and nesting
aterial (sizzle nest, Datesand Ltd, Manchester, UK). Environmen-
al enrichment was provided in the form of chew blocks and
ardboard tubes (Datesand Ltd, Manchester, UK). A seven-day accli-
ation period was given prior to the start of the study. The animal
oom was maintained at 23 ◦C ± 1 ◦C, 48% humidity and on a 12/12 h
ight dark cycle (lights on at 07:00). Food CRM (P); SDS Ltd, Essex,
K and tap water were provided ad libitum.
.2. Sample size
A sample size calculation was carried out using G*Power (V.3.1.)
sing data from Leach et al. (2012) and assumed power of 80%.
alculations indicated a minimum sample size n = 6.
.3. Data collection
.3.1. Baseline data collection
Mice were placed individually into small custom made cham-
ers (80 × 80 × 80 mm3) for a six minute habituation period.
ollowing this, close up, high deﬁnition (HD) images of their faces
ere recorded during a 3 min  session. Mice were then immediatelyiour Science 172 (2015) 58–62 59
placed individually in clear plastic cages (350 × 200 × 140 mm3)
(Techniplast UK Ltd, London, UK) that contained only bedding. The
behaviour of each individual was  recorded, in HD for 10 min  using
a video camera (HDR-XR155, Sony, Japan) positioned at a ﬁxed dis-
tance from the cage. Following ﬁlming the mice were returned to
their home cages.
2.3.2. Post-buprenorphine data collection
One day following baseline data collection, mice were weighed
and administered 0.05 mg/kg buprenorphine (Vetergesic’, Reckitt-
Coleman, Hull, UK) subcutaneously into the scruff of the animal.
Forty-ﬁve minutes later, the process of collecting images of their
face and video recording of their behaviour (described above),
was repeated in order to determine if buprenorphine (BUP) alone
resulted in any changes in MGS  or behaviour. This dose of buprenor-
phine was  used as it represents a recommended dose of analgesia
of for mice following a surgical procedure (Flecknell, 2009).
2.3.3. Post-isoﬂurane data collection
Forty-eight hours following the buprenorphine data collection,
anaesthetic only control data were collected. Anaesthesia was
induced in a perspex anaesthetic induction chamber (VetTech Solu-
tions Ltd, Cheshire, UK) with isoﬂurane in oxygen (induction 5%,
2 L/min). Anaesthesia was  then maintained (2.5%, 1.0 L/min) for
10 min  to represent the duration of abdominal surgery (Leach et al.,
2012). Mice were then allowed to recover. During the recovery
phase, mice were monitored until able to walk around the cage.
Thirty minutes following recovery, the process of collecting images
of their faces and video recording of their behaviour (described
above), was repeated in order to determine if isoﬂurane anaesthesia
alone (ISO) resulted in any changes in MGS  or behaviour.
Following a surgical procedure, mice are most intensely moni-
tored during and immediately following recovery from anaesthesia.
In this study, we opted to focus our assessment during the time
frame equivalent to this phase.
Although data were collected in the same order for each mouse
(i.e. baseline, BUP then ISO), it has been previously demonstrated
that there is no change in MGS  score when control mice are placed
into the ﬁlming boxes on three separate occasions (Miller and
Leach, 2015).
No adverse or unexpected events occurred following the admin-
istration of either isoﬂurane or buprenorphine. Data were collected
from every animal at each stage of the study and all data were used
in statistical analysis.
2.4. Data collection
2.4.1. Behaviour
A 6-min epoch of video sequence of each mouse at each time
point (baseline, post-buprenorphine, post-isoﬂurane anaesthesia)
was analysed manually with ‘Cowlog 2.11’ (Hanninen and Pastell,
2009) using the ethogram shown in Table 1. Analysis was limited to
only 6 min  due to the extremely time consuming nature of manual
scoring of mouse behaviour.
2.4.2. MGS
The HD close up ﬁlming was viewed and screen shots were taken
on every occasion that a clear image of the mouse’s face was visi-
ble with the exception of when the mouse was grooming. These
images were then cropped, leaving only the face of the mouse
in the image. Using a random number generator (www.Random.
org), one image per mouse, per time point was  selected. Using the
random sequence generator, the selected images were re-ordered
and inserted into a custom designed Microsoft Excel ﬁle. Observers
who were blinded to the experimental details, design and purpose
scored each photograph using the ﬁve action units of the MGS  as
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Table 1
Behaviours scored and analysed during this study. Behaviours previously identiﬁed
as  being pain associated behaviours were grouped together during analysis to pro-
duce a composite ‘pain behaviour score’. The behaviours included in this composite
score are indicated in column 3.
Behaviour Deﬁnition Pain behaviour group?
Climb Vertical movement up cage
sides
No
Hop Hopping movement across
the cage ﬂoor
No
Walk Movement across cage
ﬂoor using all 4 limbs
No
Chew bedding Gnawing sawdust bedding No
Rearing Standing on rear legs, full
or partial stretch
No
Groom Grooming of the body,
head, limbs or tail
No
Inactive No movement around the
cage
No
Stagger Partial loss of balance
when walking
Yes
Raised tail When walking, tail is
raised from the ﬂoor
Yes
Rear leg lift One rear leg is lifted brieﬂy
straight out behind the
body
Yes
Shake Rapid side to side
movement of the body
Yes
Twitch Rapid contraction of the
back muscles
Yes
Writhe Contortion of abdominal
muscles
Yes
Flinch Small movement involving
whole body
Yes
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Fig. 1. Box plot of MGS  scores in DBA/2 mice at baseline and following either isoﬂu-
rane anaesthesia or 0.05 mg/kg buprenorphine alone. The whisker FAU was excluded
from the analysis (maximum obtainable score was  8).
Table 2
Signiﬁcant changes in duration of time spent displaying behaviours between
baseline and isoﬂurane (ISO) or buprenorphine (BUP) groups. NS, no signiﬁcant
difference, number given is p value.
Behaviour CBA mice DBA/2 mice
Walk Base < BUP 0.025 NS
Hop Base < BUP 0.017 NS
Climb Base > BUP 0.012 NS
2012), its major limitation is the time taken to develop these indicesBelly press Pressing of abdomen
toward cage ﬂoor
Yes
escribed by Langford et al. (2010). A MGS  manual was  provided
o the scorers for training and reference, but the title of the manual
as edited to ‘mouse facial action coding manual’ to limit bias-
ng of scores from the title. Observers also received a short 10 min
raining session, detailing each of the action units. This has been
he standard practice in our MGS  studies conducted to date and
as achieved high levels of both inter- and intra-observer reliabil-
ty. Scores for each FAU for every individual photograph were then
ombined to produce a global MGS  score for each image. As multi-
le individuals scored the images, the mean global score was then
alculated.
.5. Statistical analysis
Data were analysed using SPSS software. Behaviour data and
GS  data were analysed non-parametrically. A Mann–Whitney
 test compared the CBA to DBA/2 mice at each time point. A
riedman’s test was used to compare MGS  and behaviour scores
ver time, with post hoc analysis being carried out with Wilcoxon
igned-rank test with a Bonferroni Correction for Multiple Compar-
sons being applied. Results were considered statistically signiﬁcant
hen p < 0.05.
. Results
.1. Mouse grimace scale
Due to the high number of failed attempts to score the whiskers,
his facial action unit was excluded from analysis. Maximum MGS
core was therefore 8 rather than 10. No signiﬁcant difference was
ound between CBA and DBA/2 mice at any individual time points
hroughout the study.Inactive Base < BUP 0.012 NS
Chew bedding Base < BUP 0.017 NS
Rearing Base > BUP 0.012 NS
In CBA mice, there was no signiﬁcant difference in MGS  scores
between baseline compared to either post isoﬂurane anaesthesia
or the buprenorphine administration. In DBA/2 mice, there was no
signiﬁcant difference in MGS  scores at baseline compared to post
buprenorphine administration. However, the MGS  score follow-
ing isoﬂurane anaesthesia was signiﬁcantly higher than at baseline
(p < 0.05) (Fig. 1).
3.2. Behaviour
A composite ‘pain behaviours’ group was  included as indicated
in Table 1. Behaviours in this category were those previously iden-
tiﬁed to occur following potentially painful procedure in mice and
occur extremely infrequently in control/baseline animals (Wright-
Williams et al., 2007; Miller et al., 2012; Leach et al., 2012).
Signiﬁcant changes in the duration of time spent displaying cer-
tain behaviours were found in the ISO and BUP groups compared
to baseline (Table 2 for full list of changes and associated p val-
ues). Changes in these behaviours were only identiﬁed in the CBA
mice and not the DBA/2 mice. Most notably, CBA mice spent sig-
niﬁcantly longer walking (Fig. 2) and chewing bedding following
a dose of buprenorphine compared to baseline (p < 0.05 for both
comparisons).
4. Discussion
Behavioural analysis is a key method used in assessment of
welfare (Sneddon et al., 2014). Although behavioural-based assess-
ment represents an effective means of assessing pain in laboratory
mice (Wright-Williams et al., 2007; Miller et al., 2012; Leach et al.,and then to train observers to use them effectively (Roughan and
Flecknell, 2006). Due to the expanding use of mice in biomedical
research and the time consuming nature of developing relevant
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Fig. 2. Box plots of duration of walking during 6 min  of analysis, in CBA mice at
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thogram for new procedures and strains, novel rapid methods of
ssessment should be investigated and validated for use. The MGS
as previously shown promise in for the effective assessment of
ain in mice (Langford et al., 2010; Leach et al., 2012), but requires
urther validation before it can be widely implemented in clinical
cenarios. In this study, we have investigated the inﬂuence of isoﬂu-
ane anaesthesia and buprenorphine analgesia in non-painful mice
o establish whether these procedures inﬂuence exhibition of pain
ehaviours and the MGS  in two common mouse strains. Under-
tanding whether these non-painful procedures, that are often
ntegral to research procedures, have any effect on our assessment
ethods is critical to their further validation.
Limited changes in spontaneous behaviour were observed
etween before and after isoﬂurane anaesthesia or buprenor-
hine administration. Key, previously validated, pain associated
ehaviours such as belly pressing, twitching, ﬂinching and writhing
ere not inﬂuenced by the administration of anaesthesia or
uprenorphine alone. These subtle behaviours are vitally important
n pain assessment of mice. They do not occur at baseline and their
resence is noted following various routine laboratory procedures
hen analgesic provision is inadequate (Wright-Williams et al.,
007, 2013; Kawaura et al., 2011). The changes in behaviour follow-
ng anaesthesia and analgesia that were demonstrated here were in
ine with previous studies which noted administration of buprenor-
hine increases activity (e.g. walking and hopping) in non-painful
ice (Cowan et al., 1977; Tubbs et al., 2011; Wright-Williams
t al., 2013). The increase in duration of time spent chewing bed-
ing following buprenorphine administration, may  represent pica
ehaviour which is thought to be a sign of nausea and has previ-
usly been associated with the administration of buprenorphine in
at (Clark et al., 1997). There is some evidence that mice also dis-
lay pica behaviour (Yamamoto et al., 2002) although it is thought
o be highly strain dependent and a less robust measure than in the
at (Stern et al., 2011).
Blind scoring with the mouse grimace scale revealed no change
n scores between baseline and following administration of either
soﬂurane anaesthesia or buprenorphine in CBA mice. However,
soﬂurane did increase the MGS  score compared to baseline in
BA/2 mice. This is an important ﬁnding and should be considered
hen attempting to score pain in this strain of mouse using the MGS
f isoﬂurane anaesthesia is included in the research protocol, par-
icularly when no baseline data are available for each animal. Like
any published studies, this ﬁnding again highlights the impor-
ance of being familiar with the speciﬁc strain of mice being studied,
s there is increasing evidence of considerable variation betweeniour Science 172 (2015) 58–62 61
strains in terms of their reactions to various procedures. In contrast
to the speciﬁc pain behaviours, which either do not occur, or occur
at a very low level when a painful stimulus is not present, the mouse
grimace scale score at baseline is not zero. This is also reported in
other studies (Leach et al., 2012; Miller and Leach, 2015), and must
be considered when assessing mice using the MGS, particularly if
baseline MGS  scores are not available.
5. Conclusion
Behaviour is commonly used for assessing pain in mice with
many speciﬁc pain associated behaviours having been previously
identiﬁed (e.g. Wright-Williams et al., 2007). To effectively use
these behavioural indices, we must be conﬁdent that their pres-
ence, in a given strain, is linked to pain and not another effect of
the procedure. Here we  demonstrated that isoﬂurane anaesthesia
or a single dose of buprenorphine did not result in the presence
of any speciﬁc previously identiﬁed, pain associated behaviours in
CBA or DBA/2 mice.
A single 0.05 mg/kg s.c. injection had no effect on mouse grimace
scale score in either DBA/2 or CBA male mice. Isoﬂurane anaesthe-
sia of 10 min  duration results in an increase in MGS  score in DBA/2
mice and this effect should be considered when attempting to use
the MGS  in pain assessment following procedure requiring isoﬂu-
rane anaesthesia (e.g. surgery) in this strain of mouse. Further work
should be carried out to establish the presence of this isoﬂurane
effect in other strains and the inﬂuence of gender to increase the
validity of this method for pain assessment.
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